Prokaryotic ribosome small subunit (30S subunit)

The prokaryotic ribosome small subunit, commonly called the 30S subunit, is one of the two structural and functional components of the bacterial ribosome (the other being the large or 50S subunit)[7][2][1][3]. The 30S subunit is a ribonucleoprotein complex consisting of a single 16S ribosomal RNA (rRNA) molecule and approximately 19–21 distinct ribosomal proteins[7][1][8]. During translation, the small subunit binds to messenger RNA (mRNA) and reads the nucleotide sequence, enabling the accurate positioning and decoding necessary for protein synthesis[7][1][10]. It is critical for the initiation step of translation, ensuring correct identification of the translation start site. The 30S subunit is a validated therapeutic target for multiple classes of antibiotics (e.g., tetracycline, aminoglycosides like gentamicin), which inhibit bacterial protein synthesis by interfering with subunit function or formation[7]. These drugs exploit differences between prokaryotic and eukaryotic ribosomes but can sometimes also affect mitochondrial ribosomes in humans, leading to notable safety concerns[7]. In summary, the prokaryotic ribosome small subunit is a key molecular machine essential for translating genetic information into proteins—a process fundamental for bacterial viability and growth[7][3]. It is a primary target for several classes of clinically important antibiotics used to treat bacterial infections.

Other names

30S ribosomal subunit30S small subunitprokaryotic 30Sbacterial small ribosomal subunit

Inhibition of mRNA decoding, Inhibition of tRNA binding, Interruption of Shine-Dalgarno binding, Blockade of translocation during translation